BYL Nair Hospital Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2004
NCT00643045
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Alternative names

B.Y.L. Nair Hospital & T.N. Medical College, Mumbai, India

Active Ingredients

Drugs in Phase 3 Trials (1)

safinamide (xadago) (1 trial)

Drugs in Phase 2 Trials (3)

arhalofenate (1 trial)

pioglitazone (actos) (1 trial)

sitagliptin (januvia) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Parkinson Disease (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 4